Abstract
Nonalcoholic fatty liver disease (NAFLD), the most common kind of ongoing liver disease, is influenced by a diverse combination of pathogenic factors including obesity, insulin resistance, and hyperlipemia. Foxtail millet (FM) and quinoa (QA) are common small whole-grain cereals that may decrease the risk of these chronic diseases. In this study, their differences concerning hepatic steatosis, and their targets for modulating gut microbiota and its metabolites in relation to NAFLD were investigated for the first time. After 12 weeks, FM supplementation reduced liver fat accumulation, weight gain and serum triglycerides (TG), while enhancing insulin sensitivity. Similarly, QA supplementation decreased hepatic lipid deposition and ameliorated hyperlipidemia. Both of them modulated gut microbiota composition: FM increased the relative abundance of Faecalibaculum and norank_f_Muribaculaceae, whereas QA enriched Lactobacillus, Akkermansia, and norank_f_Muribaculaceae. In addition, FM had greater effects on fecal metabolic function, significantly elevating levels of L-aspartic acid and melatonin while reducing that of PA(16:0/15:0) and phenyllactic acid. QA similarly lowered PA(16:0/15:0) and phenyllactic acid concentrations. Findings suggest that the potentials to alleviate high-fat diet (HFD)-induced NAFLD were associated with improvements in gut microbiota and metabolic function.
京公网安备11010802044758号
Comments on this article